What if there was a simple blood test that could detect and screen for multiple cancers at once? This is what researcher's across the country are trying to learn in the Vanguard Study! We are looking ...
Hosted on MSN
Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study
Tryptamine’s phase 1b study of IV-infused psilocin meets all objectives Lead asset TRP-8803 found safe at low, mid and upper dose levels Planning underway to advance TRP-8803 in phase II trials ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback